Categories AlphaGraphs, Earnings, Technology
Cognizant (CTSH) Earnings: Key numbers from Q2 2020 results
Expects FY20 adj. diluted EPS in the range of $3.48-3.58
Cognizant Technology Solutions Corp. (NASDAQ: CTSH) today announced its second quarter financial results for the period ended June 30, 2020.
Net income for the second quarter was $361 million, or $0.67 per share, compared to net income of $509 million, or $0.90 per share in the second quarter of 2019.
Revenues decreased 3.4% to $4.0 billion.
“We made progress against our cost structure initiative allowing us to fund investments aligned to our long-term growth strategy and delivered solid operating performance in a challenging environment. Strong free cash flow further strengthened our balance sheet and provides us with ample financial flexibility.”
Karen McLoughlin, Chief Financial Officer
Check out the past quarters performance:
COVID-19 puts insurers in tricky situation; risks range from litigation to insolvency
Ravaging almost every part of the world and crippling economic activity, the coronavirus pandemic has not spared any business. When it comes to the insurance industry, the nature of impact is complex and there is no doubt the companies will struggle with their underwriting decisions once the damage is fully assessed.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company